Eastman Chemical Company
EMN
$75.28
-$0.23-0.31%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.75B | 9.02B | 9.29B | 9.36B | 9.38B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.75B | 9.02B | 9.29B | 9.36B | 9.38B |
| Cost of Revenue | 6.91B | 6.96B | 7.05B | 7.03B | 7.09B |
| Gross Profit | 1.85B | 2.06B | 2.24B | 2.33B | 2.30B |
| SG&A Expenses | 633.00M | 619.00M | 638.00M | 659.00M | 664.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.79B | 7.84B | 7.95B | 7.95B | 8.00B |
| Operating Income | 958.00M | 1.18B | 1.34B | 1.42B | 1.38B |
| Income Before Tax | 568.00M | 853.00M | 999.00M | 1.12B | 1.08B |
| Income Tax Expenses | 93.00M | 152.00M | 164.00M | 191.00M | 170.00M |
| Earnings from Continuing Operations | 475.00 | 701.00 | 835.00 | 926.00 | 908.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -2.00M | -3.00M | -4.00M | -3.00M |
| Net Income | 474.00M | 699.00M | 832.00M | 922.00M | 905.00M |
| EBIT | 958.00M | 1.18B | 1.34B | 1.42B | 1.38B |
| EBITDA | 1.47B | 1.69B | 1.85B | 1.92B | 1.89B |
| EPS Basic | 4.13 | 6.06 | 7.20 | 7.94 | 7.77 |
| Normalized Basic EPS | 3.62 | 4.91 | 5.75 | 6.28 | 6.06 |
| EPS Diluted | 4.08 | 5.99 | 7.12 | 7.86 | 7.68 |
| Normalized Diluted EPS | 3.58 | 4.85 | 5.68 | 6.21 | 6.00 |
| Average Basic Shares Outstanding | 458.60M | 460.20M | 462.20M | 464.50M | 466.70M |
| Average Diluted Shares Outstanding | 463.00M | 465.00M | 467.40M | 469.80M | 471.50M |
| Dividend Per Share | 3.33 | 3.32 | 3.30 | 3.28 | 3.26 |
| Payout Ratio | 80.38% | 54.51% | 45.67% | 41.21% | 41.88% |